MSA
AGN

Mason Street Advisors’s Allergan Inc AGN Stock Holding History

Mason Street Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-48,429
Closed -$10.3M – 1923
2014
Q4 		$10.3M Sell
48,429
-222
-0.5% -$44.1K 0.07% 327
2014
Q3 		$8.67M Sell
48,651
-160
-0.3% -$26.6K 0.07% 346
2014
Q2 		$8.26M Sell
48,811
-529
-1% -$82.4K 0.06% 367
2014
Q1 		$6.12M Sell
49,340
-30
-0.1% -$3.65K 0.05% 432
2013
Q4 		$5.48M Sell
49,370
-6,702
-12% -$640K 0.04% 473
2013
Q3 		$5.07M Sell
56,072
-58,432
-51% -$5.25M 0.06% 350
2013
Q2 		$9.65M Buy
+114,504
New +$11.9M 0.11% 250

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Mason Street Advisors's AGN Position: Q1 2015 in Review

Mason Street Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 48,429 shares — an estimated $10.3M sold.

Mason Street Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $10.3M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Mason Street Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Mason Street Advisors sold 48,429 Allergan Inc shares in Q1 2015, an estimated $10.3M.
  • Mason Street Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Mason Street Advisors's Allergan Inc position peaked at $10.3M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.